A randomized controlled trial of rivaroxaban for the prevent of major cardiovascular events in patients with coronaryor periphery artery disease (COMPASS - Cardiovascular OutcoMes for People using Anticoagulation)

Administered By

Awarded By

Contributors

Start/End

  • December 1, 2013 - November 30, 2020